13F-HR: Ventas, Inc. Q1 2026 13F Holdings Disclosure

Ventas, Inc. reports a single equity holding in Ardent Health, Inc. valued at approximately $79.97 million as of March 31, 2026.

Summary

• Ventas, Inc. filed its Form 13F for the quarter ended March 31, 2026.
• The report discloses a single investment position in Ardent Health, Inc. (Common Stock).
• The total value of the reported holdings is $79,971,809.
• The position consists of 9,342,501 shares held with sole investment discretion.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure of existing holdings with no new strategic or financial guidance provided.

Positives

• Clear and transparent disclosure of investment holdings as required by SEC regulations.
• Maintains sole voting and investment authority over the reported position.

Negatives

• Limited scope of disclosure as the report only lists one equity holding.

Risks

• Concentration risk associated with holding a single equity position in the healthcare sector.
• Market volatility affecting the valuation of the Ardent Health, Inc. stake.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future investment strategy.

Industry Context

StockSavvy.ai notes that this 13F filing reflects the specific equity investment profile of Ventas, Inc., a major healthcare REIT, focusing on strategic interests within the healthcare services sector.

Comparison to Industry Standards

• The filing adheres to standard SEC 13F reporting requirements for institutional investment managers.
• The disclosure format is consistent with industry practices for quarterly equity holdings reporting.

Stakeholder Impact

• Provides transparency to shareholders regarding the company's equity investment portfolio.

Next Steps

• Monitor future 13F filings for changes in equity positions.

Key Dates

Keywords

Ventas, 13F, Ardent Health, Institutional Holdings, SEC Filing, Investment Management